InSilicoMinds CEO Nirnith Devireddy attended Avicenna Days 2026.
Published
Signal category
Presence & Recognition
Quote
“A quick glimpse of our CEO Nirnith Devireddy at Avicenna Days 2026.”
— InSilicoMinds team
Company
InSilicoMinds
AI, Modeling & Simulation for Pharma, Life Sciences, & Medical Device Companies.
- Industry
- Information Technology & Services
- Location
- San Diego, US
- Company size
- 11 employees
InSilicoMinds specializes in providing AI and advanced modeling and simulation solutions for Pharma & Life Sciences. We leverage the best of breed validated global solutions and service providers to offer the best in class in silico solutions which help our clients optimize their drug development cycle, reduce costs, save time, and improve patient outcomes. InSilicoMinds enhances its portfolio of computational solutions through an exclusive partnership with InSilicoTrials, a premier provider of AI and simulation tools for drug development, reflecting both companies' commitment to innovation and excellence in advancing drug research and development. We are a team of experienced life sciences, digital innovation, and in silico experts that work together to provide our in silico solution. Our team has extensive experience working with a wide range of pharmaceutical and life sciences clients, from small startups to large multinational corporations. We understand the unique challenges facing these industries, and we have the knowledge and expertise to help our clients succeed. Expertise -In Silico Modeling & Simulation -Bioinformatics & Computational Biology/Chemistry -Clinical Research & In Silico Trials -Domain Advisory & Consultancy -Staff Augmentation
Founded 2021